Headquartered in Uppsala, Sweden, Senzime is publicly traded on the Nasdaq Stockholm Main Market (SEZI), with cross-trading on the US OTCQX Market (SNZZF), and backed by long-term investors. More ...
Original Image Link
Source:www.biospace.com
Original Image Link
Source:www.biospace.com
Posted: 2026-10-17 05:00:00









